A new Center for Blood Cancers will be the domain for a world-class program for multiple myeloma care and research, thanks to a $75 million anonymous donation made in support of Perlmutter Cancer Center's campaign to enhance its state-of-the art research and clinical space.
The center will provide more patient services, increase and foster research efforts, hold educational resources for both students at NYU School of Medicine, and expand lab space and cell processing. It will focus on clinical trial recruitment and identifying markers for blood cancers in order to catch them at the earliest stage.
"There is a pressing need for more research in the areas of early diagnosis and prevention of blood cancers," says Benjamin Neel, MD, PhD, director of the Perlmutter Cancer Center. "As a nationally recognized cancer center, we are proud to continue to be on the leading edge of research and clinical care in this area. This gift will help us as attract new talent, leaders and added expertise to further our mission to prevent and treat these deadly diseases."
about the author
Myeloma Crowd Editorial Contributor, Nursing student, and cancer advocate.